Abstract

This review aimed to comprehensively assess the efficacy and safety of oral East Asian herbal medicine (EAHM) for overall peripheral neuropathy (PN). In addition, an Apriori algorithm-based association rule analysis was performed to identify the core herb combination, thereby further generating useful hypotheses for subsequent drug discovery. A total of 10 databases were searched electronically from inception to July 2021. Randomized clinical trials (RCTs) comparing EAHM with conventional analgesic medication or usual care for managing PN were included. The RCT quality was appraised using RoB 2.0, and the random effects model was used to calculate the effect sizes of the included RCTs. The overall quality of evidence was evaluated according to the Grading of Recommendations Assessment, Development, and Evaluation. By analyzing the constituent herb data, the potential association rules of core herb combinations were explored. A total of 67 RCTs involving 5753 patients were included in this systematic review. In a meta-analysis, EAHM monotherapy and combined EAHM and western medicine therapy demonstrated substantially improved sensory nerve conduction velocity, motor nerve conduction velocity, and response rate. Moreover, EAHM significantly improved the incidence rate, pain intensity, Toronto clinical scoring system, and Michigan diabetic neuropathy score. The evidence grade was moderate to low due to the substantial heterogeneity among the studies. Nine association rules were identified by performing the association rule analysis on the extraction data of 156 EAHM herbs. Therefore, the constituents of the herb combinations with consistent association rules were Astragali Radix, Cinnamomi Ramulus, and Spatholobi Calulis. This meta-analysis supports the hypothesis that EAHM monotherapy and combined therapy may be beneficial for PN patients, and follow-up research should be conducted to confirm the precise action target of the core herb.

Highlights

  • The main finding of this study is that East Asian herbal medicine (EAHM) monotherapy or combined EAHM and WM therapy was superior to the control group without EAHM in improving nerve conduction velocity, response rate, incidence rate, pain intensity, and other overall symptoms

  • In the association rule analysis of various EAHM prescription data included in this study, Astragali Radix, Cinnamomi Ramulus, and Spatholobi Calulis were identified as components constituting the core herb combination

  • It is envisaged that relevant drug discovery information will be generated through a comparison of the phytochemical and clinical effectiveness with those of conventional herbal medicine in follow-up investigations. This meta-analysis supports the hypothesis that EAHM monotherapy may be beneficial for peripheral neuropathy (PN) patients

Read more

Summary

Introduction

Peripheral neuropathy (PN) is one of the most common causes for a patient to visit the clinic [1]. The prevalence of diabetic peripheral neuropathy (DPN) or herpetic neuropathy, the commonly observed PNs, is at least 10–20% [2,3]. It is not easy to collect the available PN epidemiological data since the causes of pathology are very diverse. The symptoms can develop in a single affected area, and in multiple nerves [4]. Symptoms that may occur due to this disease include chronic pain, decreased nerve conduction velocity (NCV), sensation loss, and abnormal sensations such as tingling, Pharmaceuticals 2021, 14, 1202.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call